Cargando…
Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition
Understanding the emerging models of adaptive resistance is key to overcoming cancer chemotherapy failure. Using human breast cancer explants, in vitro cell lines, mouse in vivo studies and mathematical modelling, here we show that exposure to a taxane induces phenotypic cell state transition toward...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Pub. Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339891/ https://www.ncbi.nlm.nih.gov/pubmed/25669750 http://dx.doi.org/10.1038/ncomms7139 |
_version_ | 1782358934679453696 |
---|---|
author | Goldman, Aaron Majumder, Biswanath Dhawan, Andrew Ravi, Sudharshan Goldman, David Kohandel, Mohammad Majumder, Pradip K. Sengupta, Shiladitya |
author_facet | Goldman, Aaron Majumder, Biswanath Dhawan, Andrew Ravi, Sudharshan Goldman, David Kohandel, Mohammad Majumder, Pradip K. Sengupta, Shiladitya |
author_sort | Goldman, Aaron |
collection | PubMed |
description | Understanding the emerging models of adaptive resistance is key to overcoming cancer chemotherapy failure. Using human breast cancer explants, in vitro cell lines, mouse in vivo studies and mathematical modelling, here we show that exposure to a taxane induces phenotypic cell state transition towards a favoured transient CD44(Hi)CD24(Hi) chemotherapy-tolerant state. This state is associated with a clustering of CD44 and CD24 in membrane lipid rafts, leading to the activation of Src Family Kinase (SFK)/hemopoietic cell kinase (Hck) and suppression of apoptosis. The use of pharmacological inhibitors of SFK/Hck in combination with taxanes in a temporally constrained manner, where the kinase inhibitor is administered post taxane treatment, but not when co-administered, markedly sensitizes the chemotolerant cells to the chemotherapy. This approach of harnessing chemotherapy-induced phenotypic cell state transition for improving antitumour outcome could emerge as a translational strategy for the management of cancer. |
format | Online Article Text |
id | pubmed-4339891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Nature Pub. Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-43398912015-03-02 Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition Goldman, Aaron Majumder, Biswanath Dhawan, Andrew Ravi, Sudharshan Goldman, David Kohandel, Mohammad Majumder, Pradip K. Sengupta, Shiladitya Nat Commun Article Understanding the emerging models of adaptive resistance is key to overcoming cancer chemotherapy failure. Using human breast cancer explants, in vitro cell lines, mouse in vivo studies and mathematical modelling, here we show that exposure to a taxane induces phenotypic cell state transition towards a favoured transient CD44(Hi)CD24(Hi) chemotherapy-tolerant state. This state is associated with a clustering of CD44 and CD24 in membrane lipid rafts, leading to the activation of Src Family Kinase (SFK)/hemopoietic cell kinase (Hck) and suppression of apoptosis. The use of pharmacological inhibitors of SFK/Hck in combination with taxanes in a temporally constrained manner, where the kinase inhibitor is administered post taxane treatment, but not when co-administered, markedly sensitizes the chemotolerant cells to the chemotherapy. This approach of harnessing chemotherapy-induced phenotypic cell state transition for improving antitumour outcome could emerge as a translational strategy for the management of cancer. Nature Pub. Group 2015-02-11 /pmc/articles/PMC4339891/ /pubmed/25669750 http://dx.doi.org/10.1038/ncomms7139 Text en Copyright © 2015, Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ |
spellingShingle | Article Goldman, Aaron Majumder, Biswanath Dhawan, Andrew Ravi, Sudharshan Goldman, David Kohandel, Mohammad Majumder, Pradip K. Sengupta, Shiladitya Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition |
title | Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition |
title_full | Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition |
title_fullStr | Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition |
title_full_unstemmed | Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition |
title_short | Temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition |
title_sort | temporally sequenced anticancer drugs overcome adaptive resistance by targeting a vulnerable chemotherapy-induced phenotypic transition |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339891/ https://www.ncbi.nlm.nih.gov/pubmed/25669750 http://dx.doi.org/10.1038/ncomms7139 |
work_keys_str_mv | AT goldmanaaron temporallysequencedanticancerdrugsovercomeadaptiveresistancebytargetingavulnerablechemotherapyinducedphenotypictransition AT majumderbiswanath temporallysequencedanticancerdrugsovercomeadaptiveresistancebytargetingavulnerablechemotherapyinducedphenotypictransition AT dhawanandrew temporallysequencedanticancerdrugsovercomeadaptiveresistancebytargetingavulnerablechemotherapyinducedphenotypictransition AT ravisudharshan temporallysequencedanticancerdrugsovercomeadaptiveresistancebytargetingavulnerablechemotherapyinducedphenotypictransition AT goldmandavid temporallysequencedanticancerdrugsovercomeadaptiveresistancebytargetingavulnerablechemotherapyinducedphenotypictransition AT kohandelmohammad temporallysequencedanticancerdrugsovercomeadaptiveresistancebytargetingavulnerablechemotherapyinducedphenotypictransition AT majumderpradipk temporallysequencedanticancerdrugsovercomeadaptiveresistancebytargetingavulnerablechemotherapyinducedphenotypictransition AT senguptashiladitya temporallysequencedanticancerdrugsovercomeadaptiveresistancebytargetingavulnerablechemotherapyinducedphenotypictransition |